Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline.
Dynamic Colon Model (DCM)
PBBM
PBPK
SimCyp®
USP II
dissolution testing
in silico modelling
in vitro model
modified release (MR)
pharmacokinetics
theophylline
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
09 Mar 2023
09 Mar 2023
Historique:
received:
13
02
2023
revised:
25
02
2023
accepted:
07
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
A physiologically based biopharmaceutic model (PBBM) of a modified-release formulation of theophylline (Uniphyllin Continus
Identifiants
pubmed: 36986743
pii: pharmaceutics15030882
doi: 10.3390/pharmaceutics15030882
pmc: PMC10058579
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MC_PC_18040
Pays : United Kingdom
Références
Pharmaceutics. 2021 Sep 23;13(10):
pubmed: 34683837
J Pharm Sci. 2016 Oct;105(10):3088-3096
pubmed: 27449228
Am J Gastroenterol. 1997 Jan;92(1):114-8
pubmed: 8995949
Pharm Res. 2005 Aug;22(8):1215-26
pubmed: 16078131
Magn Reson Med. 2011 Sep;66(3):812-20
pubmed: 21381105
J Pharm Pharmacol. 2012 Jul;64(7):944-68
pubmed: 22686342
Adv Drug Deliv Rev. 2021 Nov;178:113924
pubmed: 34390774
Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G922-9
pubmed: 11292601
Eur J Pharm Sci. 2001 Jul;13(4):375-84
pubmed: 11408152
Pharmaceutics. 2022 Oct 14;14(10):
pubmed: 36297627
Pharmaceuticals (Basel). 2021 May 18;14(5):
pubmed: 34070160
Am J Clin Nutr. 1992 Jan;55(1 Suppl):299S-308S
pubmed: 1728844
Pharm Res. 2020 Oct 29;37(12):233
pubmed: 33123802
Eur J Pharm Biopharm. 2016 Nov;108:9-17
pubmed: 27531624
Gut. 1988 Aug;29(8):1035-41
pubmed: 3410329
Drug Metab Dispos. 2015 Nov;43(11):1823-37
pubmed: 26296709
Eur J Clin Pharmacol. 1986;30(6):691-7
pubmed: 3770063
Pharm Res. 2004 Apr;21(4):585-91
pubmed: 15139514
J Morphol. 2004 Mar;259(3):308-15
pubmed: 14994329
Pharmaceutics. 2021 Jan 26;13(2):
pubmed: 33530468
Pharmaceutics. 2019 Feb 22;11(2):
pubmed: 30813323
Int J Pharm. 2022 Sep 25;625:122055
pubmed: 35926752
Pharmaceutics. 2019 Mar 27;11(4):
pubmed: 30934716
Eur J Pharm Sci. 2009 Sep 10;38(2):147-55
pubmed: 19591927
Eur J Pharm Biopharm. 2008 Oct;70(2):421-8
pubmed: 18582568
Pharmaceutics. 2022 Jul 21;14(7):
pubmed: 35890408
Pharmaceutics. 2020 Jul 13;12(7):
pubmed: 32668624
Drug Metab Dispos. 2019 Feb;47(2):114-123
pubmed: 30420404
Neurogastroenterol Motil. 2019 Feb;31(2):e13451
pubmed: 30129117
Neurogastroenterol Motil. 2010 Apr;22(4):366-80
pubmed: 20377792
Neurogastroenterol Motil. 2013 Jan;25(1):e52-9
pubmed: 23228077
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1210-22
pubmed: 15935870
Pharm Res. 1995 Jul;12(7):1049-54
pubmed: 7494801
Drug Dev Ind Pharm. 2007 Apr;33(4):475-83
pubmed: 17523011
Mol Pharm. 2010 Oct 4;7(5):1374-87
pubmed: 20698545
Eur J Pharm Sci. 2001 Jul;13(4):411-6
pubmed: 11408156
Eur J Pharm Biopharm. 2011 Feb;77(2):313-9
pubmed: 21055466
Front Pediatr. 2022 May 12;10:840710
pubmed: 35652056
Pharm Res. 2010 Oct;27(10):2187-96
pubmed: 20676736